Hospital News and Research

RSS

Repligen granted Notice of Allowance covering use of uridine for treatment of bipolar disorder

Repligen Corporation announced today that the United States Patent and Trademark Office has granted a Notice of Allowance of a patent covering the use of uridine in the treatment of patients with bipolar disorder. The patent, which upon issue will remain in force until 2025 prior to any patent term extensions, covers the use of an effective dose of a uridine composition to improve one or more of the symptoms of bipolar disorder including depression, mania, mixed episodes, hypomania and anxiety.

30 Apr 2010

HemCon Medical Technologies to ask for reversal of jury verdict in chitosan patent case

HemCon Medical Technologies, Inc., announced today that it will ask a US District Court in New Hampshire to review and reverse a jury verdict based on a patent held by Marine Polymer Technologies, Inc. The jury awarded damages of $29.4 million against HemCon in the patent case. HemCon will ask the Court to review the validity of the patent and reverse the damage award.

30 Apr 2010

Researchers use healthy person's complete genome sequence to predict risk for dozens of diseases

For the first time, researchers have used a healthy person's complete genome sequence to predict his risk for dozens of diseases and how he will respond to several common medications. The risk analysis, from the Stanford University School of Medicine, also incorporates more-traditional information such as a patient's age and gender and other clinical measurements.

30 Apr 2010

Data mining of hospital information can help identify MDROs: Asolva

Infection control within hospitals is a huge and growing problem. A recent study in the Archives of Internal Medicine found that conditions caused by healthcare associated infections killed 48,000 people and increased healthcare costs by $8.1 billion in 2006 alone.

30 Apr 2010

LifePoint Hospitals' first-quarter 2010 revenues up 6.9%

LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2010.

30 Apr 2010

First Edition: April 30, 2010

Today's headlines focus on state decisions regarding new health insurance pools; insurers' plans regarding the early adoption of some reform law provisions; and, of course, the politics that continue to surround health reform.

30 Apr 2010

MEDSEEK to enhance online experience for UNC Health Care patients

MEDSEEK, the industry's only provider of the eHealth ecoSystem, today announced its engagement to enhance the online experience for UNC Health Care patients.

30 Apr 2010

Accurate reporting of errors can reduce preventable hospital deaths: SIOP

People go to hospitals to be treated for an illness or for corrective surgery with the expectation they will return home in much better health than when they entered the medical facility.

30 Apr 2010

Nationwide Children's Hospital opens first pediatric Pseudotumor Cerebri Clinic in the U.S.

While most headaches in children can be treated with over-the-counter pain medications or lifestyle changes, it is important to pay attention to their symptoms in case they herald something more serious.

30 Apr 2010

CBC, Scarab Genomics form agreement to increase manufacturing yield of Solinex rhu-pGSN

Critical Biologics Corporation (CBC) and Scarab Genomics announced today a strategic agreement to substantially increase the manufacturing yield of CBC's lead therapeutic protein candidate, Solinex™, an intravenous formulation of recombinant human plasma gelsolin (rhu-pGSN).

30 Apr 2010

Study identifies extracapsular LNI as a negative prognostic factor for esophageal cancer

There is increasing evidence to include combined neoadjuvant chemoradiotherapy (CRT) as an alternative to surgical resection alone, to improve survival for locoregional esophageal cancer. More recently, attention has focused on the presence of extracapsular lymph node involvement (LNI), which identifies a subgroup of patients with significantly worse long-term survival. Little is known about the effects of neoadjuvant chemoradiotherapy (CRT) on the presence of extracapsular LNI and its prognostic value in patients with resected esophageal cancer.

30 Apr 2010

CTCA installs Calypso's real-time tumor tracking technology at Southwestern Regional Medical Center

Calypso Medical Technologies, Inc., a developer of non-ionizing real-time localization technology used for the precise tracking of tumor targets, and Cancer Treatment Centers of America, a national network of hospitals providing a comprehensive, fully integrative approach to cancer treatment, announced today that with the installation of the Calypso System at the CTCA at Southwestern Regional Medical Center in Tulsa, Okla., Calypso's real-time tumor tracking technology is now available at all CTCA centers nationwide.

30 Apr 2010

Male and female babies respond to stress during pregnancy differently

University of Adelaide research is showing that the sex of the baby determines the way it responds to stressors during pregnancy and its ability to survive pregnancy complications.

30 Apr 2010

Approval of Provenge marks beginning of new era in cancer treatment: Dana-Farber Cancer Institute

Today's announcement that the U.S. Food and Drug Administration has approved Provengeâ, a new form of therapy for some prostate cancer patients, marks the beginning of an era in which patients' own immune systems become part of the standard therapeutic arsenal against cancer, say Dana-Farber Cancer Institute investigators who led a study of the treatment's effectiveness in patients.

30 Apr 2010

CDC presents clinical trial results of Biojector 2000 at 13th Annual Conference on Vaccine Research

Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems (NFITS), today announced that the Centers for Disease Control and Prevention (CDC) and its collaborating institutions presented the latest results of its clinical trial of the Biojector® 2000 at the 13th Annual Conference on Vaccine Research, sponsored by the National Foundation for Infectious Diseases and held in Bethesda, Maryland April 26 - 28, 2010.

30 Apr 2010

No single immunosuppressive medication increases cancer risk in kidney transplant recipients

Drugs taken by kidney transplant recipients to prevent organ rejection carry similar risks of cancer, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that no single medication is to blame for the higher incidence of cancer seen among patients who have undergone transplantation.

30 Apr 2010

UIC introduces new "no stress" diagnostic system for heart failure assessment

The University of Illinois Medical Center at Chicago is the first academic medical center in the country to introduce a new "no stress" diagnostic system for assessing patients with heart failure and optimizing their treatment.

30 Apr 2010

Lucile Packard Children's Hospital opens new Center for Fetal Health

Complex fetal diagnoses bring extraordinary strain to pregnant women and their families. Learning an eagerly-awaited child will be born with a medical problem is often the worst crisis an expectant parents can face.

30 Apr 2010

IRX Therapeutics and Japan's NCRC collaborate to evaluate peptide-based cancer vaccines

IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.

30 Apr 2010

Health care reform in Massachusetts improves minority access for inpatient procedures: Researchers

Researchers from the Department of Veterans Affairs and Boston University School of Medicine have found that health care reform in Massachusetts has improved minority access for some inpatient procedures. These findings are being presented today at the annual Society of General Internal Medicine annual meetings in Minneapolis, Minnesota.

30 Apr 2010

Hospital News and Research

Repligen granted Notice of Allowance covering use of uridine for treatment of bipolar disorder

HemCon Medical Technologies to ask for reversal of jury verdict in chitosan patent case

Researchers use healthy person's complete genome sequence to predict risk for dozens of diseases

Data mining of hospital information can help identify MDROs: Asolva

LifePoint Hospitals' first-quarter 2010 revenues up 6.9%

First Edition: April 30, 2010

MEDSEEK to enhance online experience for UNC Health Care patients

Accurate reporting of errors can reduce preventable hospital deaths: SIOP

Nationwide Children's Hospital opens first pediatric Pseudotumor Cerebri Clinic in the U.S.

CBC, Scarab Genomics form agreement to increase manufacturing yield of Solinex rhu-pGSN

Study identifies extracapsular LNI as a negative prognostic factor for esophageal cancer

CTCA installs Calypso's real-time tumor tracking technology at Southwestern Regional Medical Center

Male and female babies respond to stress during pregnancy differently

Approval of Provenge marks beginning of new era in cancer treatment: Dana-Farber Cancer Institute

CDC presents clinical trial results of Biojector 2000 at 13th Annual Conference on Vaccine Research

No single immunosuppressive medication increases cancer risk in kidney transplant recipients

UIC introduces new "no stress" diagnostic system for heart failure assessment

Lucile Packard Children's Hospital opens new Center for Fetal Health

IRX Therapeutics and Japan's NCRC collaborate to evaluate peptide-based cancer vaccines

Health care reform in Massachusetts improves minority access for inpatient procedures: Researchers

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News